CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 256 filers reported holding CUBIST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $4,060,000 | -78.3% | 40,338 | -85.7% | 0.48% | -57.1% |
Q3 2014 | $18,717,000 | -52.1% | 282,130 | -49.6% | 1.12% | -35.1% |
Q2 2014 | $39,046,000 | -13.7% | 559,239 | -9.6% | 1.73% | +44.0% |
Q1 2014 | $45,248,000 | +2.6% | 618,553 | -3.4% | 1.20% | +52.6% |
Q4 2013 | $44,098,000 | -4.1% | 640,324 | -11.5% | 0.79% | +3.6% |
Q3 2013 | $46,006,000 | +13.1% | 723,921 | -14.0% | 0.76% | +38.9% |
Q2 2013 | $40,665,000 | – | 842,093 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |